Amit Gupta Sells 23,416 Shares of Cardlytics, Inc. (NASDAQ:CDLX) Stock

Cardlytics, Inc. (NASDAQ:CDLX) COO Amit Gupta sold 23,416 shares of the business’s stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $11.91, for a total transaction of $278,884.56. Following the transaction, the chief operating officer now owns 122,676 shares in the company, valued at $1,461,071.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Cardlytics Trading Up 0.6 %

CDLX stock opened at $11.59 on Friday. Cardlytics, Inc. has a 52 week low of $4.94 and a 52 week high of $20.52. The company’s 50-day simple moving average is $11.20 and its 200 day simple moving average is $9.65. The company has a debt-to-equity ratio of 1.91, a quick ratio of 1.31 and a current ratio of 1.31. The company has a market capitalization of $558.05 million, a PE ratio of -3.35 and a beta of 1.44.

Cardlytics (NASDAQ:CDLX) last posted its quarterly earnings data on Thursday, March 14th. The company reported ($0.14) earnings per share for the quarter. Cardlytics had a negative return on equity of 25.38% and a negative net margin of 43.56%. The firm had revenue of $89.17 million for the quarter.

Wall Street Analysts Forecast Growth

CDLX has been the topic of a number of recent analyst reports. Lake Street Capital boosted their target price on shares of Cardlytics from $13.00 to $18.00 and gave the stock a “buy” rating in a report on Friday, March 15th. Craig Hallum upgraded shares of Cardlytics from a “hold” rating to a “buy” rating and upped their price objective for the company from $10.00 to $18.00 in a report on Friday, March 15th. Finally, Needham & Company LLC upped their price objective on shares of Cardlytics from $15.00 to $17.00 and gave the company a “buy” rating in a report on Tuesday, April 9th.

Institutional Investors Weigh In On Cardlytics

Institutional investors and hedge funds have recently bought and sold shares of the company. Tower Research Capital LLC TRC lifted its position in Cardlytics by 349.3% during the fourth quarter. Tower Research Capital LLC TRC now owns 9,602 shares of the company’s stock worth $88,000 after purchasing an additional 7,465 shares during the period. D L Carlson Investment Group Inc. bought a new position in shares of Cardlytics in the third quarter worth about $173,000. SG Americas Securities LLC lifted its holdings in shares of Cardlytics by 34.3% in the fourth quarter. SG Americas Securities LLC now owns 21,461 shares of the company’s stock worth $198,000 after acquiring an additional 5,484 shares during the last quarter. Clear Street Markets LLC bought a new position in shares of Cardlytics in the fourth quarter worth about $199,000. Finally, Check Capital Management Inc. CA lifted its holdings in shares of Cardlytics by 14.0% in the fourth quarter. Check Capital Management Inc. CA now owns 23,200 shares of the company’s stock worth $214,000 after acquiring an additional 2,850 shares during the last quarter. Institutional investors own 68.10% of the company’s stock.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.